DPIIT recognised startup Government of India
Startup India
Captavis Biocare Private Limited
Captavis Biocare Private Limited - pharma in Bavla, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹17 Cr
▲ 368% YoY
Net profit · FY 2025
₹7.02 Lakh
Net margin 0.4%
EBITDA · FY 2025
₹2.71 Cr
EBITDA margin 15.9%
Authorised capital
₹9 Cr
Registered with MCA
Paid-up capital
₹9 Cr
Issued & subscribed
Open charges
₹26.02 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Employees · EPFO
55
Provident fund records
About Captavis Biocare Private Limited
Data last updated:
Captavis Biocare Private Limited is a private limited company based in Bavla, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2021PTC121485. Its GSTIN is 24AAJCC3794K1Z9 (Gujarat).
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹9 Cr. It is led by directors including Akash Prakashbhai Patel and Meet Savjibhai Khambhadiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 52 Survey No – 108 (Old Ls – 127), Ozone Industrial Park Bhayla Bavla Ahmedabad, Gujarat, India – 382240.
As per the financials filed for FY 2025, the company reported a revenue of ₹17 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹7.02 Lakh (net margin 0.4%) and EBITDA of ₹2.71 Cr (EBITDA margin 15.9%).
The company has about 55 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹26.02 Cr on record. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in March 2022. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Synkromax Biotech Private Limited with revenue of ₹17.03 Cr.
Captavis Biocare Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0094778).
Company details
CIN U24290GJ2021PTC121485
Registration Number 121485
Incorporation Date 23 March 2021
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification MSME
Udyam Registration UDYAM-GJ-01-0094778
Key People
Akash Prakashbhai Patel Director Meet Savjibhai Khambhadiya Director Prakashbhai Kunvarjibhai Patel Director Recognitions & Rankings of Captavis Biocare
MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-GJ-01-0094778
Contact details
Captavis Biocare Private Limited's registered office is in Bavla, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No – 52 Survey No – 108 (Old Ls – 127), Ozone Industrial Park Bhayla Bavla Ahmedabad, Gujarat, India – 382240
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Captavis Biocare Private Limited, buy the company report.
Comprehensive company report
Captavis Biocare Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Captavis Biocare is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Captavis Biocare Private Limited, buy the company report.
Financials of Captavis Biocare Private Limited
FY 2025 filings availableCaptavis Biocare Private Limited reported revenue of ₹17 Cr (up 368% YoY) for FY 2025.
Revenue · FY 2025
₹17 Cr ▲ 368%
Net profit · FY 2025
₹7.02 Lakh margin 0.4%
EBITDA · FY 2025
₹2.71 Cr margin 15.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 368%
EBITDA CAGR growth
1 year
▲ 520%
Revenue rose 368% in the latest year. EBITDA rose 520% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.71 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.9% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Captavis Biocare Private Limited, buy the company report.
Board of directors of Captavis Biocare Private Limited
Captavis Biocare has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akash Prakashbhai Patel | Director | 24 Jul 2021 | 5 Years 3 Months | Current |
| Meet Savjibhai Khambhadiya | Director | 24 Jul 2021 | 5 Years 3 Months | Current |
| Prakashbhai Kunvarjibhai Patel | Director | 24 Jul 2021 | 5 Years 3 Months | Current |
| Dhirubhai Naranbhai Kanetiya | Director | 24 Jul 2021 | 5 Years 3 Months | Current |
| Pareshkumar Prabhubhai Kanetiya | Director | 24 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
Captavis Biocare Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synkromax Biotech Private Limited | ₹17.03 Cr (FY 2024) | 15.0% | Thirumazhisai, Tamil Nadu, India | |||
| Anchor Pharma Private Limited | ₹17.02 Cr (FY 2025) | 11.0% | Daman, Daman and Diu, India | |||
| Skinselect Private Limited | ₹17.02 Cr (FY 2025) | 20.0% | Mumbai, Maharashtra, India | |||
| Nahta Salt and Chemical Private Limited | ₹17.01 Cr (FY 2025) | 27.0% | Gandhidham, Gujarat, India | |||
| Grandeur Business Solutions Private Limited | ₹17 Cr (FY 2024) | 112.0% | New Delhi, Delhi, India | |||
| Captavis Biocare Private Limitedthis company | ₹17 Cr (FY 2025) | ₹7.02 Lakh | 0.4% | 368.0% | 55 | Bavla, Gujarat, India |
| G T Pest Control Private Limited | ₹17 Cr (FY 2019) | 4.0% | Pune, Maharashtra, India | |||
| Cropel Lifesciences Private Limited | ₹16.99 Cr (FY 2024) | -22.0% | Kalol, Gujarat, India | |||
| Rangoon Chemical Works Pvt Ltd | ₹16.99 Cr (FY 2025) | 5.0% | Surat, Gujarat, India | |||
| Amar Sulpha Chem Private Limited | ₹16.98 Cr (FY 2025) | -16.0% | Bareilly, Uttar Pradesh, India | |||
| Leaders Healthcare Private Limited | ₹16.98 Cr (FY 2025) | -7.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Captavis Biocare Private Limited, buy the company report.
Auditor
Captavis Biocare Private Limited is audited by Shah Soni & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Shah Soni & Associates | FY 2024 | 139263W |
Shareholding
The shareholding of Captavis Biocare Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Captavis Biocare Private Limited, buy the company report.
Charges & borrowings
Open charges
₹26.02 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Jun 2022 | 100586067 | Others | ₹26.02 Cr | Open |
To see the full charge records of Captavis Biocare Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Captavis Biocare Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in March 2022.
Total deals
2
Rights issue
1
Secondary share transfer
1
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 3 individuals |
| Aug 2021 | Rights issue | ₹4.99 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Captavis Biocare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Captavis Biocare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Captavis Biocare Private Limited has a workforce of 55 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
55
Active EPFO establishments
1
Employee growth
-9.8%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 55 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Captavis Biocare Private Limited, buy the company report.
GST
Captavis Biocare has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCC3794K1Z9 | Gujarat | Active | 05 Sep 2021 |
To see the full GST registrations and return filing status of Captavis Biocare Private Limited, buy the company report.
Recent activity
Captavis Biocare Private Limited has 15 board changes on record since 2021: 5 appointments and 10 cessations. The latest: Vallabh Champaklal Lakadia ceased to be Director on 30 Jan 2025.
AGM
Captavis Biocare Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Captavis Biocare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Vallabh Champaklal Lakadia ceased to be Director.
Charges
A charge with Others of Rs. 26.02 Cr registered on 01 Jun 2022 with Charge ID 100586067 was modified on 29 Feb 2024.
Charges
A charge with Others amounted to Rs. 26.02 Cr with Charge ID 100586067 was registered on 01 Jun 2022.
Ceased
Akash Prakashbhai Patel ceased to be Additional Director.
Ceased
Dhirubhai Naranbhai Kanetiya ceased to be Additional Director.
Ceased
Hardik Vallabhbhai Lakadia ceased to be Additional Director.
Ceased
Meet Savjibhai Khambhadiya ceased to be Additional Director.
Ceased
Nisarg Vallabhbhai Lakadia ceased to be Additional Director.
Ceased
Pareshkumar Prabhubhai Kanetiya ceased to be Additional Director.
Ceased
Prakashbhai Kunvarjibhai Patel ceased to be Additional Director.
8 earlier events are in the company report.
Frequently asked questions
Captavis Biocare is an active private limited company based in Bavla, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 March 2021 (5+ years old) and is registered under CIN U24290GJ2021PTC121485.
Captavis Biocare has 5 current directors:
- Akash Prakashbhai Patel - Director
- Meet Savjibhai Khambhadiya - Director
- Prakashbhai Kunvarjibhai Patel - Director
- Dhirubhai Naranbhai Kanetiya - Director
- Pareshkumar Prabhubhai Kanetiya - Director
The latest financial statements of Captavis Biocare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Captavis Biocare is 24AAJCC3794K1Z9, registered in Gujarat.
The CIN (Corporate Identification Number) of Captavis Biocare is U24290GJ2021PTC121485. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Captavis Biocare was incorporated on 23 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Captavis Biocare has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in March 2022.
The peers of Captavis Biocare by revenue are Synkromax Biotech Private Limited, Anchor Pharma Private Limited, Skinselect Private Limited, Nahta Salt and Chemical Private Limited, Grandeur Business Solutions Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vallabh Champaklal Lakadia ceased to be Director on 30 Jan 2025. Akash Prakashbhai Patel ceased to be Additional Director on 30 Nov 2021. Dhirubhai Naranbhai Kanetiya ceased to be Additional Director on 30 Nov 2021. Captavis Biocare has 15 board changes on record in total.
Yes, Captavis Biocare is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Captavis Biocare is registered as an MSME under Udyam registration (number: UDYAM-GJ-01-0094778).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages